Monsanto, Stanley .
HRN: 22-06-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2023
CEFTRIAXONE 1G (VIAL)
04/10/2023
04/17/2023
IV
600mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes